HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ho-Jin Shin Selected Research
Ho-Jin Shin Research Topics
Disease
25
Multiple Myeloma
12/2021 - 12/2009
20
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2022 - 12/2008
15
Lymphoma (Lymphomas)
01/2022 - 09/2007
10
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2007
9
Neoplasms (Cancer)
01/2022 - 01/2010
6
Neutropenia
10/2022 - 05/2012
5
Febrile Neutropenia
10/2022 - 05/2012
4
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 09/2011
4
Leukemia
01/2022 - 06/2009
4
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 12/2010
4
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 01/2009
4
Aplastic Anemia (Anemia, Hypoplastic)
01/2020 - 07/2009
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 01/2015
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 01/2010
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2017 - 11/2009
4
Disease Progression
10/2015 - 02/2008
3
Infections
10/2022 - 12/2014
3
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2022 - 06/2008
3
Pain (Aches)
01/2022 - 07/2019
3
Hemorrhage
01/2021 - 12/2014
3
Philadelphia Chromosome
12/2017 - 01/2003
2
Myalgia
01/2022 - 10/2019
2
Hemophilia A (Haemophilia)
09/2021 - 09/2019
2
Breast Neoplasms (Breast Cancer)
09/2021 - 03/2019
2
idiopathic Aplastic anemia
01/2020 - 10/2013
2
Hodgkin Disease (Hodgkin's Disease)
11/2019 - 12/2013
2
Anemia
11/2019 - 11/2009
2
Fatigue
10/2019 - 07/2019
2
T-Cell Lymphoma (Lymphoma, T Cell)
10/2016 - 01/2009
2
Plasmacytoma
04/2015 - 11/2014
1
Thrombocytopenia (Thrombopenia)
07/2022
1
Asthenia
01/2022
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1
Spinal Cord Injuries (Spinal Cord Injury)
08/2021
1
Hemophilia B (Haemophilia B)
01/2021
1
Frailty
01/2021
1
Low Back Pain (Lumbago)
01/2020
1
Neck Pain (Cervicalgia)
01/2020
Drug/Important Bio-Agent (IBA)
16
Rituximab (Mabthera)
FDA Link
10/2022 - 12/2008
15
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2022 - 06/2008
11
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2022 - 06/2008
10
Vincristine (Oncovin)
FDA Link
Generic
10/2022 - 06/2008
10
Bortezomib (Velcade)
FDA Link
01/2021 - 01/2010
9
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021 - 01/2010
8
Prednisone (Sone)
FDA Link
Generic
01/2022 - 12/2008
7
Melphalan (Alkeran)
FDA Link
Generic
01/2022 - 06/2012
6
Prednisolone (Predate)
FDA Link
Generic
10/2022 - 06/2008
6
Busulfan (Busulfex)
FDA Link
01/2022 - 09/2011
6
Thalidomide (Thalomid)
FDA Link
01/2021 - 02/2010
5
Etoposide (VP 16)
FDA Link
Generic
01/2022 - 11/2013
5
Lenalidomide (CC 5013)
FDA Link
01/2021 - 01/2019
5
Imatinib Mesylate (Gleevec)
FDA Link
12/2017 - 11/2009
5
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
09/2015 - 08/2009
4
R-CHOP protocol
IBA
10/2022 - 12/2008
4
Cyclosporine (Ciclosporin)
FDA Link
Generic
03/2015 - 01/2009
3
Inosine Triphosphate (ITP)
IBA
07/2022 - 06/2008
3
Ferritins (Ferritin)
IBA
04/2020 - 12/2009
3
Core Binding Factors (Core-Binding Factor)
IBA
05/2019 - 06/2010
3
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2015 - 01/2007
2
pegfilgrastim (Neulasta)
FDA Link
10/2022 - 10/2022
2
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
01/2022 - 12/2019
2
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2020 - 09/2011
2
daratumumab
IBA
01/2020 - 12/2018
2
Monoclonal Antibodies
IBA
10/2019 - 12/2018
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
03/2019 - 02/2015
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2019 - 05/2012
2
thymoglobulin
FDA Link
03/2015 - 10/2013
2
Azacitidine (5 Azacytidine)
FDA Link
12/2014 - 01/2010
2
Anti-Bacterial Agents (Antibiotics)
IBA
07/2013 - 06/2008
2
Biomarkers (Surrogate Marker)
IBA
09/2011 - 01/2010
1
Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)
IBA
10/2022
1
TOR Serine-Threonine Kinases
IBA
01/2022
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2022
1
theasinensin A
IBA
01/2022
1
Roflumilast
IBA
01/2022
1
polatuzumab vedotin
IBA
01/2022
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2021
1
Antibodies
IBA
09/2021
1
Factor IX (Coagulation Factor IX)
FDA Link
Generic
01/2021
1
Bendamustine Hydrochloride
FDA Link
04/2020
1
Proteasome Inhibitors
IBA
01/2020
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2020
1
Immunologic Factors (Immunomodulators)
IBA
01/2020
1
pomalidomide
IBA
01/2020
1
Salts
IBA
01/2020
Therapy/Procedure
25
Drug Therapy (Chemotherapy)
10/2022 - 09/2007
20
Therapeutics
01/2021 - 06/2008
19
Stem Cell Transplantation
01/2022 - 01/2009
6
Hematopoietic Stem Cell Transplantation
01/2020 - 04/2004
5
Induction Chemotherapy
01/2016 - 03/2007
3
Transplantation
01/2018 - 01/2009
2
Remission Induction
01/2021 - 06/2009
2
Radiotherapy
03/2019 - 10/2016
2
Cell Transplantation
08/2015 - 09/2011
2
Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2009 - 01/2003
1
Meditation
01/2022
1
Exoskeleton Device
08/2021
1
Induced Hyperthermia (Thermotherapy)
01/2020
1
Mud Therapy (Mud Bath)
01/2020
1
Aftercare (After-Treatment)
01/2020